PCL

본문 바로가기

팝업레이어 알림

팝업레이어 알림이 없습니다.
pcl

Technology
Multi-immune source technology-based platform capable of diagnosing various diseases
Pipeline

HiSU Solution : High throughput screening platform

Platform Product line​ Product name​ Details​
HiSU Solution
High throughput ​ screening platform​
blood donor screening​ Hi3-1
  • · World's first multi-immune high-risk virus blood screening product.
  • · new health technology NET certification​
  • · Selected as an excellent product for innovative procurement ​
Hi3 Plus
Hi4-TP combo
Multiple cancer screening​ Ci5
  • · Semi-quantitative blood test for tumor markers in five major cancers
    (liver cancer, pancreatic cancer, colon cancer, breast cancer, prostate cancer)​
  • · new health technology NET certification​
  • · World's first multi-immune cancer screening product​
autoimmune semi-quantitative testing​ Ana7
  • · multiplex semi-quantitative detection kit of seven autoimmune markers​
  • · Success of purchase conditional business (Ministry of SMEs and startups)​
  • · Joint development with Gangnam St. Mary's Hospital, Seoul​
Alzheimer's testing​ Dm5
  • · Joint R&D with Swiss pharmaceutical company NEURIX and Geneva University Hospital​
  • · new health technology NET certification​

PCLOK Solution : POCT platform​

Platform Category Model Details
PCLOK Solution
POCT system
Blood screening of High-risk viruses for Small blood center and LMIC Hi06&Hi07
  • · High-risk virus screening before blood transfusion
  • · HIVㆍHBVㆍHCVㆍTP Immunoassay
  • · NET(New Excellent Technology) certificated
  • · CTS (KOICA ODA for Africa) selected product
Tumor marker
Multiplex Immunoassay
Ci02&Ci03
  • · Quantitative detection for Multiple Tumor marker
  • · Pancreatic, Liver, Colorectal, Prostate, Ovarian cancer (CA19-9, AFP, CEA, PSA, CA125)
Respiratory virus Ri01
  • · Multiple detection for antigens of Influenza A/B + RSV
  • · Joint development with Pulmonology at Samsung Seoul hospital
Ri02
  • · Multiple detection for antigens of Influenza A/B + COVID-19
Ri03
  • · Multiple detection of lgG antibodies for 2 major antigens of COVID-19(S1, NP)
Antibody Titer test
for Dog/Cat Vaccination
Vi01
  • · Antibody titer test for Dog vaccination
  • · CDV, CPV, CPIV, CAV-2, CCoV
Vi02
  • · Antibody titer test for Cat vaccination
  • · FCV, FPV, FVR, FIP, Chlamydia
  • · Collaborative project of Seoul Business Agency

COVID-19 Total Solutions

platform Family Status by Product Details
COVID19 Solution PCL MD
Genetic Testing Key
MD01
(PCLMD nCoV one step RT-PCR Kit)
  • Molecular diagnostic reagents for high-risk infections (grade 3)​
  • Respiratory virus gene detection kit 'Fast time with high sensitivity' among more than 12 foreign countries including Germany, Spain, Ukraine, Singapore, the Arab Emirates, Saudi Arabia, Indonesia, India, Iraq, Uzbekistan and Colombia.​
  • MD01&MD02 Molecular diagnostic kit of COVID19 is possible on existing equipment within 45 minutes​
  • breakthrough product with NA01 RNA Preparation time reduced to less than 10 minutes​
  • 'Speedy Bag' From swab to results in 30 minutes.​
MD02
(PCLMD COVID19 Speedy RT-PCR Kit)
MD03
(PCLMD ABC multi RT-PCR)
Speedy bag
(30min Portable RT-PCR All-in-one Bag)
Antigen Test Key COV05
(PCL COVID19 Ag Rapid FIA)
  • Antigen diagnostic Kit for Respiratory Virus (COVID19) Fluorescence Search
  • Exporting to 18 overseas countries including Germany, USA, Italy, Spain, Portugal, Australia, Saudi Arabia, Poland, Switzerland, Ghana, Ukraine, Morocco, Colombia, Qatar, Angola, Tanzania, Brazil, Greece, Russia, Hungary, Chile, Ireland and Mexico​
  • Global Airport Solution, Urgent Innovations product​
COV04S
(PCL COVID19 Ag Gold)
  • Respiratory virus COVID19 antigen saliva self-diagnosis kit​
  • Can check the diagnosis result through saliva and nasopharynx in 10 minutes​
  • Clinical sensitivity 94.29% Clinical specificity 99.99%
  • official products that used in the Austrian state of Burgenland​
Ri02
(PCLOK II Influenza A, Influenza B, COVID19)
  • Multiple Respiratory Virus Detection Kit​
  • Using high-sensitivity SG Cap technology Influenza and COVID-19 on-site detection kit​
  • First high-sensitivity respiratory virus test kit for three types​
Antibody Test Kit​ COV03​
(PCL COVID19 IgG/IgM Rapid Gold)
  • On-site antibody diagnostic kit for Covid-19 respiratory infection virus​
  • Exporting to 32 overseas countries including Germany, Italy, Spain, Hungary, Poland, Switzerland, Saudi Arabia, Colombia, Qatar, Morocco, Sudan, Malaysia, Indonesia, Guatemala and Uganda​
PCL HiSU COVID19 Neutralizing Ab test
  • Respiratory Virus COVID19 Neutralized Antibody Screening Kit​
  • Neutralized antibody ELISA diagnostic kit​​
  • Mass immunodynamic testing possible
PCLOK II Anti-SARS-CoV-2 Dual IgG​
  • Respiratory Virus COVID19 IgG Antibody diagnostic Kit​​
  • IgG antibody kit that can detect NP and Spike proteins ​
  • Provide useful information on epidemiological investigations and the development of therapeutic vaccines
COV01​
(PCL COVID19 Total Ab EIA)​
  • Respiratory Virus COVID19 Total Anti-Body Screening Kit​​
  • Antibody ELISA Diagnostic Kit
  • Availability for mass immunodynamic testing, usage by the Centers for Disease Control and Prevention​